Indivior Pharmaceuticals (INDV) Exchange Rate Effect (2024 - 2025)
Indivior Pharmaceuticals (INDV) posted quarterly Exchange Rate Effect of -$2.0 million for Q3 2025, down 100.0% year-over-year from -$inf billion in Q3 2024, and down 300.0% quarter-over-quarter from $1.0 million in Q2 2025.
Indivior Pharmaceuticals (INDV) Exchange Rate Effect (2024 - 2025) Analysis & Trends
Indivior Pharmaceuticals' Exchange Rate Effect history runs 2 years deep, the most recent figure standing at -$2.0 million for Q3 2025.
- In Q3 2025, Exchange Rate Effect fell 100.0% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$1.0 million (changed N/A YoY), while the FY2025 annual figure was -$1.0 million, changed N/A from the prior year.
- Exchange Rate Effect for Q3 2025 stood at -$2.0 million, down from $1.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.0 million in Q4 2024, with the low at -$2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.00 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Sep 30, 2024 | -1.00 Mn |